Study of Radiolabeled ALXN2050 in Healthy Adult Males
Clinical trial NCT04609670 · COMPLETED
Trial details
- NCT number
- NCT04609670
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2021-08-23
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.